Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

Endo Will Acquire Drug Partner Penwest

by Rick Mullin
August 16, 2010 | A version of this story appeared in Volume 88, Issue 33

Endo Pharmaceuticals plans to acquire drug delivery technology specialist Penwest Pharmaceuticals in a cash deal valued at about $168 million. The two companies have worked together since 1997 developing the extended-release pain relief drug Opana. They are currently working on a crush-resistant version of Opana with Grunenthal, a German drugmaker. Endo recently filed a New Drug Application for the formulation with FDA.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.